273 related articles for article (PubMed ID: 38391997)
1. Aptamer-Based Targeting of Cancer: A Powerful Tool for Diagnostic and Therapeutic Aims.
Mohammadinejad A; Gaman LE; Aleyaghoob G; Gaceu L; Mohajeri SA; Moga MA; Badea M
Biosensors (Basel); 2024 Jan; 14(2):. PubMed ID: 38391997
[TBL] [Abstract][Full Text] [Related]
2. Progress and Challenges in Developing Aptamer-Functionalized Targeted Drug Delivery Systems.
Jiang F; Liu B; Lu J; Li F; Li D; Liang C; Dang L; Liu J; He B; Badshah SA; Lu C; He X; Guo B; Zhang XB; Tan W; Lu A; Zhang G
Int J Mol Sci; 2015 Oct; 16(10):23784-822. PubMed ID: 26473828
[TBL] [Abstract][Full Text] [Related]
3. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
Zhong Y; Zhao J; Li J; Liao X; Chen F
Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
[TBL] [Abstract][Full Text] [Related]
4. Advances in Aptamers-Based Applications in Breast Cancer: Drug Delivery, Therapeutics, and Diagnostics.
Gholikhani T; Kumar S; Valizadeh H; Mahdinloo S; Adibkia K; Zakeri-Milani P; Barzegar-Jalali M; Jimenez B
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430951
[TBL] [Abstract][Full Text] [Related]
5. Chimeric aptamers in cancer cell-targeted drug delivery.
Kanwar JR; Roy K; Kanwar RK
Crit Rev Biochem Mol Biol; 2011 Dec; 46(6):459-77. PubMed ID: 21955150
[TBL] [Abstract][Full Text] [Related]
6. Aptamer-Enabled Nanomaterials for Therapeutics, Drug Targeting and Imaging.
Liu M; Wang L; Lo Y; Shiu SC; Kinghorn AB; Tanner JA
Cells; 2022 Jan; 11(1):. PubMed ID: 35011722
[TBL] [Abstract][Full Text] [Related]
7. Cell-specific aptamers and their conjugation with nanomaterials for targeted drug delivery.
Liao J; Liu B; Liu J; Zhang J; Chen K; Liu H
Expert Opin Drug Deliv; 2015 Mar; 12(3):493-506. PubMed ID: 25430795
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine.
Zhuo Z; Yu Y; Wang M; Li J; Zhang Z; Liu J; Wu X; Lu A; Zhang G; Zhang B
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29036890
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the Selection of Cancer-Specific Aptamers for the Development of Biosensors.
Sousa DA; Carneiro M; Ferreira D; Moreira FTC; Sales MGF; Rodrigues LR
Curr Med Chem; 2022; 29(37):5850-5880. PubMed ID: 35209816
[TBL] [Abstract][Full Text] [Related]
10. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
[TBL] [Abstract][Full Text] [Related]
11. Aptamer applications for targeted cancer therapy.
Barbas AS; Mi J; Clary BM; White RR
Future Oncol; 2010 Jul; 6(7):1117-26. PubMed ID: 20624124
[TBL] [Abstract][Full Text] [Related]
12. Aptamers: molecular tools for medical diagnosis.
Ozalp VC; Kavruk M; Dilek O; Bayrac AT
Curr Top Med Chem; 2015; 15(12):1125-37. PubMed ID: 25866272
[TBL] [Abstract][Full Text] [Related]
13. Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine.
Xiang D; Shigdar S; Qiao G; Wang T; Kouzani AZ; Zhou SF; Kong L; Li Y; Pu C; Duan W
Theranostics; 2015; 5(1):23-42. PubMed ID: 25553096
[TBL] [Abstract][Full Text] [Related]
14. Biosensors based on aptamer-conjugated gold nanoparticles: A review.
Nooranian S; Mohammadinejad A; Mohajeri T; Aleyaghoob G; Kazemi Oskuee R
Biotechnol Appl Biochem; 2022 Aug; 69(4):1517-1534. PubMed ID: 34269486
[TBL] [Abstract][Full Text] [Related]
15. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
[TBL] [Abstract][Full Text] [Related]
16. Recent progresses in biomedical applications of aptamer-functionalized systems.
Ding F; Gao Y; He X
Bioorg Med Chem Lett; 2017 Sep; 27(18):4256-4269. PubMed ID: 28803753
[TBL] [Abstract][Full Text] [Related]
17. Aptamer-nanoparticle complexes as powerful diagnostic and therapeutic tools.
Jo H; Ban C
Exp Mol Med; 2016 May; 48(5):e230. PubMed ID: 27151454
[TBL] [Abstract][Full Text] [Related]
18. Application of aptamers in treatment and diagnosis of leukemia.
Yazdian-Robati R; Arab A; Ramezani M; Abnous K; Taghdisi SM
Int J Pharm; 2017 Aug; 529(1-2):44-54. PubMed ID: 28648578
[TBL] [Abstract][Full Text] [Related]
19. Evolution of Complex Target SELEX to Identify Aptamers against Mammalian Cell-Surface Antigens.
Mallikaratchy P
Molecules; 2017 Jan; 22(2):. PubMed ID: 28146093
[TBL] [Abstract][Full Text] [Related]
20. A Highlight of Recent Advances in Aptamer Technology and Its Application.
Sun H; Zu Y
Molecules; 2015 Jun; 20(7):11959-80. PubMed ID: 26133761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
